When should I get the COVID-19 booster vaccine? If you have received 2 doses of an mRNA vaccine (Moderna and Pfizer) or a single dose of nonreplicating viral vector (Johnson and Johnson), you are considered fully vaccinated. You should receive your booster dose: 5 months after the primar...
As of August 2023, there's no guidance on drinking alcohol before getting a COVID-19 booster or vaccine. Research on the Moderna or Pfizer vaccines did not ask trial participants to avoid alcohol.In contrast, research on the Novavax vaccine asked people with a history of alcohol use disorder...
Humoral immunity after a booster dose of COVID-19 vaccine in patients with psoriasis treated with methotrexate and biologics: acohort studydoi:10.1093/ced/llae349Kvist-Hansen AmandaHansen Cecilie BoHamm Sebastian RaskPérez-Alós LauraZachariae Claus...
Learn more: COVID-19 Vaccines: Get the Facts This is not all the information you need to know about Vicks NyQuil products for safe and effective use and does not take the place of your doctor’s directions. Review the full NyQuil Drug Facts label and discuss the use of any over-the-co...
researchers measured the COVID antibodies of 99 OHSU employees, all of whom had received the standard two-dose vaccination. They then compared the antibody levels of people who'd gotten a third booster dose against those who didn’t bother with the booster but wound up catching a natural infec...
on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans travel for the holidays. Until now, Americans faced a confusing list of...
Individuals with hematologic malignancies are at increased risk for severe coronavirus disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity are scarce. Here we present an observational study with expanded methodological analysis of a longitudinal, primarily BNT162b2 mRNA...
Since emergence of the initial SARS-CoV-2 BA.1, BA.2 and BA.5 variants, Omicron has diversified substantially. Antigenic characterization of these new variants is important to analyze their potential immune escape from population immunity and implication
Core body temperature (CBT) is a key vital sign and fever is an important indicator of disease. In the past decade, there has been growing interest for vital sign monitoring technology that may be embedded in wearable devices, and the COVID-19 pandemic has highlighted the need for remote pa...
Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile Article Open access 27 October 2023 Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year ret...